Trailing-twelve-month (TTM) revenue is $58.55 Million with a year-over-year growth of +220.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $13,380,685 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $15,167,047 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2026Period ended 2026-03-31 | $14,820,233 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $15,181,914 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $58,549,879 |
Current P/S: $101,947,464 market capitalization ÷ $58,549,879 TTM revenue = 1.74x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:44:46.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $15.18M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:47:29.125Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Advertising | $5M | $6M | $7M | $8M | $9M | $10M |
| Franchise | $2M | $3M | $2M | $3M |
$58.55M
$58.55 Million
+220.62%
vs. $18.26M a year ago (TTM)
(3.57%)
5 Year compound annual growth rate
1 Year
+220.62%
3 Year
(19.41%)
5 Year
(3.57%)
10 Year
+13.07%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $54.90M | +$2.73M | +5.24% |
| 2024 | $52.16M | +$5.19M | +11.04% |
| 2023 | $46.98M | ($54.27M) | (53.60%) |
| 2022 | $101.25M | +$21.24M | +26.55% |
| 2021 | $80.01M | +$21.33M | +36.34% |
| 2020 |
TTM Growth
+220.62%
3-Year CAGR
(19.41%)
5-Year CAGR
(3.57%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:47:29.125Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $3M |
| Product and Service, Other | $847,100 | $1M | $1M | $2M | $2M | $2M |
|---|
| Regional Developer Fees | $876,804 | $848,640 | $659,099 | N/A | N/A | N/A |
|---|
| Revenues and Management Fees from Company Clinics | $32M | $44M | $59M | $71M | N/A | N/A |
|---|
| Royalty | $16M | $22M | $26M | $29M | $32M | $33M |
|---|
| Technology Service | $3M | $3M | $4M | $5M | $6M | $6M |
|---|
| $58.68M |
| +$10.23M |
| +21.12% |
| 2019 | $48.45M | +$16.66M | +52.41% |
| 2018 | $31.79M | +$6.63M | +26.33% |
| 2017 | $25.16M | +$4.64M | +22.61% |
| 2016 | $20.52M | +$6.69M | +48.34% |
